Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
The Biochemical Journal|July 16, 2003
Variations in aggrecan structure modulate its susceptibility to aggrecanasesPeter J Roughley, James Barnett, Fengrong Zuo, et al.The Journal of Biological Chemistry|January 1, 2004
ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1Gui Gao, Anna Plaas, Vivian P Thompson, et al.Arthritis Research & Therapy|November 19, 2009
Aggrecanolysis and in vitro matrix degradation in the immature bovine meniscus: mechanisms and functional implicationsChristopher G Wilson, Eric J Vanderploeg, Fengrong Zuo, et al.Biochemistry|April 3, 2007
Kinetic characterization of human JNK2alpha2 reaction mechanism using substrate competitive inhibitorsLinghao Niu, Kung-Ching Chang, Stacy Wilson, et al.Clinical and Vaccine Immunology : CVI|October 13, 2017
Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization AssayCindy Shambaugh, Sarieh Azshirvani, Li Yu, et al.Experimental Neurology|January 8, 2008
Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extensionMichelle G Hamel, Joanne M Ajmo, Christopher C Leonardo, et al.Clinical and Vaccine Immunology : CVI|December 15, 2012
Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion proteinAnu Cherukuri, Kathryn Patton, Robert A Gasser, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 18, 2020
Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV VaccineHui Liu, Lorraine Gemmell, Rui Lin, et al.Matrix Biology : Journal of the International Society for Matrix Biology|December 19, 2006
Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical propertiesChristopher G Wilson, Ashley W Palmer, Fengrong Zuo, et al.Journal of Virological Methods|May 2, 2017
Development of a robust, higher throughput green fluorescent protein (GFP)-based Epstein-Barr Virus (EBV) micro-neutralization assayRui Lin, Darren Heeke, Hui Liu, et al.Pageof 2